Complement alternative pathway activation and control on membranes of human lymphoid B cell lines
✍ Scribed by Valérie Caudwell; FrançOise Porteu; Alain Calender; Michael K. Pangburn; Lise Halbwachs-Mecarelli
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Volume
- 20
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Alternative pathway of complement activation by stimulated T lymphocytes 11. Elevation of cytotoxic potential against complement receptor-carrying cell lines* Exposure of lectin-stimulated (concanavalin A, phytohemagglutinin and pokeweed mitogen) blood lymphocytes to human serum or to purified
## Abstract Receptors for the third component of complement (C3) were demonstrated on the surface of established human lymphoid cell lines by a membrane fluorescence test with FITC‐ or TRITC‐conjugated antibodies against human C3. Two‐color fluorescence staining of EBV receptors and C3 receptors sh
C3b and C5b deposition following complement activation, and its regulation by CD46 were studied using xenogenic Chinese hamster ovary (CHO) cells as targets and cytofluorometry. Following activation of the alternative pathway, an initial low level of C3b deposition was observed on CHO cell surfaces
## Abstract Complement (C3) receptors, EBV receptors, Fc receptors, membrane IgM and beta~2~microglobulin (β~2~m) were individually stripped from the surface of human B lymphoma lines. The cells were subsequently tested for their ability to absorb infectious EB virus. Stripping of Fc receptors, IgM
Complement regulatory proteins present on the surface of various mammalian cells play an important role in controlling homologous lysis, by interacting with C3 (and usually C4). These proteins have a similar structural motif ("short consensus repeat") (Reid, K.B.